EMCURE PHARMACEUTICALS
|
EMCURE PHARMACEUTICALS Last 5 Year Income Statement History
[Consolidated]
Mar2024 | Mar2023 | Mar2022 | Mar2021 | Mar2020 | |
---|---|---|---|---|---|
INCOME : | |||||
Gross Sales | ₹6,786 Cr | ₹6,098 Cr | ₹5,979 Cr | ₹6,250 Cr | ₹5,216 Cr |
Sales | ₹6,664 Cr | ₹5,986 Cr | ₹5,783 Cr | ₹6,136 Cr | ₹5,140 Cr |
Job Work/ Contract Receipts | - | - | - | - | - |
Processing Charges / Service Income | ₹46 Cr | ₹57 Cr | ₹108 Cr | ₹65 Cr | ₹33 Cr |
Revenue from property development | - | - | - | - | - |
Other Operational Income | ₹76 Cr | ₹55 Cr | ₹89 Cr | ₹50 Cr | ₹44 Cr |
Less: Excise Duty | - | - | - | - | - |
Net Sales | ₹6,658 Cr | ₹5,986 Cr | ₹5,855 Cr | ₹6,056 Cr | ₹5,049 Cr |
EXPENDITURE : | |||||
Increase/Decrease in Stock | ₹-190 Cr | ₹67 Cr | ₹-145 Cr | ₹-253 Cr | ₹1.91 Cr |
Raw Material Consumed | ₹2,447 Cr | ₹2,004 Cr | ₹2,173 Cr | ₹2,604 Cr | ₹1,893 Cr |
Opening Raw Materials | ₹379 Cr | ₹420 Cr | ₹402 Cr | ₹337 Cr | ₹292 Cr |
Purchases Raw Materials | ₹1,059 Cr | ₹916 Cr | ₹1,108 Cr | ₹1,331 Cr | ₹811 Cr |
Closing Raw Materials | ₹323 Cr | ₹379 Cr | ₹420 Cr | ₹402 Cr | ₹337 Cr |
Other Direct Purchases / Brought in cost | ₹1,332 Cr | ₹1,047 Cr | ₹1,082 Cr | ₹1,338 Cr | ₹1,127 Cr |
Other raw material cost | - | - | - | - | - |
Power & Fuel Cost | ₹120 Cr | ₹109 Cr | ₹97 Cr | ₹105 Cr | ₹101 Cr |
Electricity & Power | ₹120 Cr | ₹109 Cr | ₹97 Cr | ₹105 Cr | ₹101 Cr |
Oil, Fuel & Natural gas | - | - | - | - | - |
Coals etc | - | - | - | - | - |
Other power & fuel | - | - | - | - | - |
Employee Cost | ₹1,292 Cr | ₹1,117 Cr | ₹1,012 Cr | ₹1,102 Cr | ₹1,106 Cr |
Salaries, Wages & Bonus | ₹1,138 Cr | ₹977 Cr | ₹891 Cr | ₹967 Cr | ₹967 Cr |
Contributions to EPF & Pension Funds | ₹74 Cr | ₹64 Cr | ₹59 Cr | ₹68 Cr | ₹66 Cr |
Workmen and Staff Welfare Expenses | ₹59 Cr | ₹52 Cr | ₹41 Cr | ₹45 Cr | ₹46 Cr |
Other Employees Cost | ₹21 Cr | ₹24 Cr | ₹22 Cr | ₹22 Cr | ₹26 Cr |
Other Manufacturing Expenses | ₹506 Cr | ₹451 Cr | ₹478 Cr | ₹408 Cr | ₹331 Cr |
Sub-contracted / Out sourced services | - | - | - | - | - |
Processing Charges | ₹91 Cr | ₹59 Cr | ₹65 Cr | ₹58 Cr | ₹36 Cr |
Repairs and Maintenance | - | - | - | - | - |
Packing Material Consumed | ₹219 Cr | ₹189 Cr | ₹206 Cr | ₹170 Cr | ₹134 Cr |
Other Mfg Exp | ₹196 Cr | ₹202 Cr | ₹207 Cr | ₹180 Cr | ₹161 Cr |
General and Administration Expenses | ₹524 Cr | ₹484 Cr | ₹372 Cr | ₹369 Cr | ₹437 Cr |
Rent , Rates & Taxes | ₹32 Cr | ₹21 Cr | ₹22 Cr | ₹24 Cr | ₹22 Cr |
Insurance | ₹23 Cr | ₹23 Cr | ₹19 Cr | ₹21 Cr | ₹43 Cr |
Printing and stationery | ₹17 Cr | ₹14 Cr | ₹12 Cr | ₹13 Cr | ₹23 Cr |
Professional and legal fees | ₹210 Cr | ₹206 Cr | ₹155 Cr | ₹179 Cr | ₹141 Cr |
Traveling and conveyance | ₹176 Cr | ₹157 Cr | ₹105 Cr | ₹75 Cr | ₹160 Cr |
Other Administration | ₹67 Cr | ₹62 Cr | ₹58 Cr | ₹58 Cr | ₹49 Cr |
Selling and Distribution Expenses | ₹535 Cr | ₹415 Cr | ₹397 Cr | ₹357 Cr | ₹379 Cr |
Advertisement & Sales Promotion | ₹279 Cr | ₹183 Cr | ₹163 Cr | ₹118 Cr | ₹185 Cr |
Sales Commissions & Incentives | ₹130 Cr | ₹103 Cr | ₹90 Cr | ₹55 Cr | ₹56 Cr |
Freight and Forwarding | ₹126 Cr | ₹129 Cr | ₹144 Cr | ₹102 Cr | ₹59 Cr |
Handling and Clearing Charges | - | - | - | ₹82 Cr | ₹80 Cr |
Other Selling Expenses | - | - | - | - | - |
Miscellaneous Expenses | ₹195 Cr | ₹158 Cr | ₹142 Cr | ₹132 Cr | ₹96 Cr |
Bad debts /advances written off | ₹39 Cr | ₹19 Cr | ₹1.96 Cr | ₹2.53 Cr | ₹5.43 Cr |
Provision for doubtful debts | ₹13 Cr | ₹5.34 Cr | ₹5.58 Cr | ₹26 Cr | ₹2.58 Cr |
Losson disposal of fixed assets(net) | - | ₹0.33 Cr | ₹0.41 Cr | - | ₹4.16 Cr |
Losson foreign exchange fluctuations | - | - | - | - | - |
Losson sale of non-trade current investments | - | - | - | - | - |
Other Miscellaneous Expenses | ₹144 Cr | ₹133 Cr | ₹134 Cr | ₹103 Cr | ₹84 Cr |
Less: Expenses Capitalised | - | - | - | - | - |
Total Expenditure | ₹5,429 Cr | ₹4,805 Cr | ₹4,525 Cr | ₹4,824 Cr | ₹4,345 Cr |
Operating Profit (Excl OI) | ₹1,230 Cr | ₹1,181 Cr | ₹1,330 Cr | ₹1,232 Cr | ₹704 Cr |
Other Income | ₹57 Cr | ₹46 Cr | ₹63 Cr | ₹35 Cr | ₹82 Cr |
Interest Received | ₹21 Cr | ₹12 Cr | ₹10 Cr | ₹7.35 Cr | ₹2.19 Cr |
Dividend Received | - | - | - | - | - |
Profit on sale of Fixed Assets | ₹7.19 Cr | - | - | ₹0.42 Cr | - |
Profits on sale of Investments | ₹2.53 Cr | ₹0.12 Cr | - | - | - |
Provision Written Back | - | - | - | - | - |
Foreign Exchange Gains | ₹13 Cr | ₹19 Cr | ₹37 Cr | ₹15 Cr | ₹46 Cr |
Others | ₹13 Cr | ₹15 Cr | ₹16 Cr | ₹13 Cr | ₹34 Cr |
Operating Profit | ₹1,287 Cr | ₹1,227 Cr | ₹1,393 Cr | ₹1,267 Cr | ₹786 Cr |
Interest | ₹237 Cr | ₹214 Cr | ₹176 Cr | ₹198 Cr | ₹257 Cr |
InterestonDebenture / Bonds | - | - | - | - | - |
Interest on Term Loan | ₹98 Cr | ₹79 Cr | ₹70 Cr | ₹97 Cr | ₹111 Cr |
Intereston Fixed deposits | - | - | - | - | - |
Bank Charges etc | ₹28 Cr | ₹29 Cr | ₹29 Cr | ₹26 Cr | ₹16 Cr |
Other Interest | ₹111 Cr | ₹106 Cr | ₹77 Cr | ₹76 Cr | ₹129 Cr |
PBDT | ₹1,050 Cr | ₹1,013 Cr | ₹1,217 Cr | ₹1,069 Cr | ₹530 Cr |
Depreciation | ₹312 Cr | ₹260 Cr | ₹245 Cr | ₹323 Cr | ₹321 Cr |
Profit Before Taxation & Exceptional Items | ₹737 Cr | ₹753 Cr | ₹973 Cr | ₹746 Cr | ₹209 Cr |
Exceptional Income / Expenses | ₹-9.93 Cr | ₹-6.15 Cr | - | ₹-89 Cr | ₹-103 Cr |
Profit Before Tax | ₹727 Cr | ₹747 Cr | ₹973 Cr | ₹657 Cr | ₹105 Cr |
Provision for Tax | ₹200 Cr | ₹185 Cr | ₹270 Cr | ₹239 Cr | ₹4.73 Cr |
Current Income Tax | ₹203 Cr | ₹169 Cr | ₹272 Cr | ₹197 Cr | ₹30 Cr |
Deferred Tax | ₹-9.99 Cr | ₹12 Cr | ₹-16 Cr | ₹38 Cr | ₹-27 Cr |
Other taxes | ₹6.33 Cr | ₹3.81 Cr | ₹14 Cr | ₹3.74 Cr | ₹1.37 Cr |
Profit After Tax | ₹528 Cr | ₹562 Cr | ₹703 Cr | ₹419 Cr | ₹101 Cr |
Extra items | - | - | - | - | - |
Minority Interest | ₹-29 Cr | ₹-30 Cr | ₹-40 Cr | ₹-26 Cr | ₹-17 Cr |
Share of Associate | - | - | - | - | - |
Other Consolidated Items | - | - | - | - | - |
Consolidated Net Profit | ₹498 Cr | ₹532 Cr | ₹662 Cr | ₹392 Cr | ₹84 Cr |
Adjustments to PAT | - | - | - | - | - |
Profit Balance B/F | ₹2,196 Cr | ₹1,695 Cr | ₹1,744 Cr | ₹1,369 Cr | ₹1,338 Cr |
Appropriations | ₹2,695 Cr | ₹2,227 Cr | ₹2,406 Cr | ₹1,761 Cr | ₹1,422 Cr |
General Reserves | - | - | - | - | - |
Proposed Equity Dividend | - | - | - | - | - |
Corporate dividend tax | - | - | - | - | ₹5.58 Cr |
Other Appropriation | ₹24 Cr | ₹13 Cr | ₹675 Cr | ₹17 Cr | ₹20 Cr |
Equity Dividend % | ₹30.00 | ₹20.00 | ₹30.00 | ₹10.00 | ₹25.00 |
Earnings Per Share | ₹27.50 | ₹29.42 | ₹36.62 | ₹21.68 | ₹4.62 |
Adjusted EPS | ₹27.50 | ₹29.42 | ₹36.62 | ₹21.68 | ₹4.62 |
Compare Income Statement of peers of EMCURE PHARMACEUTICALS
Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
EMCURE PHARMACEUTICALS | ₹19,990.4 Cr | 3% | 5.9% | NA | Stock Analytics | |
SUN PHARMACEUTICAL INDUSTRIES | ₹424,706.0 Cr | -2.5% | 7.6% | 4.7% | Stock Analytics | |
DIVIS LABORATORIES | ₹152,946.0 Cr | -3% | 3.4% | 61.5% | Stock Analytics | |
CIPLA | ₹120,751.0 Cr | -1.6% | 3% | -3.4% | Stock Analytics | |
TORRENT PHARMACEUTICALS | ₹109,988.0 Cr | -0.3% | 9% | 22.3% | Stock Analytics | |
DR REDDYS LABORATORIES | ₹96,066.7 Cr | -1.2% | 2.9% | -6.4% | Stock Analytics |
EMCURE PHARMACEUTICALS Share Price vs Sensex
Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
EMCURE PHARMACEUTICALS | 3% |
5.9% |
|
SENSEX | -1.8% |
2.7% |
5% |
You may also like the below Video Courses